Why Invitae's Q4 Results Didn't Fire Up Investors
Invitae (NYSE: NVTA) delivered a sizzling performance in 2020, with its shares skyrocketing 159%. That sizzle fizzled somewhat last month, though, after the medical genetics company announced a dilution-causing stock offering.
The company reported its fourth-quarter results after the market closed on Wednesday. The healthcare stock slipped a little in after-hours trading. Here are the highlights from Invitae's latest quarterly update.
Image source: Getty Images.
Source Fool.com
